(Q43274523)

18 November 2017

Serotonin and the GI tract (English)

1 reference

18 November 2017

0 references

William L Hasler

1

1 reference

18 November 2017

1 October 2009

1 reference

Current gastroenterology reports

18 November 2017

1 reference

18 November 2017

11

1 reference

18 November 2017

383-391

1 reference

18 November 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-009-0058-7

18 November 2017

0 references

cites work

5-HT4 receptor agonists: similar but not the same

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-009-0058-7

A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew

21 January 2018

1 reference

12 December 2020

Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters

1 reference

12 December 2020

Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathways

1 reference

12 December 2020

Serotonin signaling in diverticular disease

1 reference

12 December 2020

Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease.

1 reference

12 December 2020

Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan

1 reference

12 December 2020

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Use of antidepressants and risk of colorectal cancer: a nested case-control study

1 reference

12 December 2020

Identification of patients with non-d, non-C irritable bowel syndrome and treatment with renzapride: an exploratory, multicenter, randomized, double-blind, placebo-controlled clinical trial.

1 reference

12 December 2020

Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors

1 reference

12 December 2020

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

1 reference

12 December 2020

5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors

1 reference

12 December 2020

Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation

1 reference

12 December 2020

Sumatriptan is an agonist at 5-HT receptors on myenteric neurones in the guinea-pig gastric antrum

1 reference

12 December 2020

Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome

1 reference

12 December 2020

Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants

1 reference

12 December 2020

First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome

1 reference

12 December 2020

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

1 reference

12 December 2020

Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment?

1 reference

12 December 2020

Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage

1 reference

12 December 2020

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

1 reference

12 December 2020

Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats

1 reference

12 December 2020

Male and female 5-HT(1B) receptor knockout mice have higher body weights than wildtypes

1 reference

12 December 2020

Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function.

1 reference

12 December 2020

Drug evaluation: Pumosetrag for the treatment of irritable bowel syndrome and gastroesophageal reflux disease.

1 reference

12 December 2020

Serotonergic signalling in the stomach and duodenum of patients with gastroparesis

1 reference

12 December 2020

The potential use of selective 5-HT2C agonists in treating obesity

1 reference

12 December 2020

Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data

1 reference

12 December 2020

Comparative activity of antiemetic drugs

1 reference

12 December 2020

The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients

1 reference

12 December 2020

Role of a serotonin precursor in development of gut microvilli

1 reference

12 December 2020

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

1 reference

12 December 2020

Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders

1 reference

12 December 2020

Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders

1 reference

12 December 2020

Serotonin pharmacology in the gastrointestinal tract: a review

1 reference

12 December 2020

The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro.

1 reference

12 December 2020

A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

1 reference

12 December 2020

CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection

1 reference

12 December 2020

The serotonin signaling system: from basic understanding to drug development for functional GI disorders

1 reference

12 December 2020

Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron

1 reference

12 December 2020

Serotonergic drugs : effects on appetite expression and use for the treatment of obesity

1 reference

12 December 2020

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Regional differences in expression of TPH-1, SERT, 5-HT(3) and 5-HT(4) receptors in the human stomach and duodenum

1 reference

12 December 2020

Cholera toxin induces sustained hyperexcitability in submucosal secretomotor neurons in guinea pig jejunum

1 reference

12 December 2020

Pharmacological targeting of the serotonergic system for the treatment of obesity

1 reference

12 December 2020

A placebo-controlled trial of prucalopride for severe chronic constipation

1 reference

12 December 2020

Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts

1 reference

12 December 2020

10.1007/S11894-009-0058-7

Identifiers

DOI

1 reference

18 November 2017

1 reference

PubMed ID

19765366